Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 98 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer				Phase III, Phase II				SGI-RUB-048 NCT00113256
	A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer				Phase III				GV-001.004 NCT00051467
	Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen				Phase III				EFC6596 XRP9881, NCT00417209
	A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.				Phase III				A6181114 NCT00428220
	Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.				Phase III				A4061028 NCT00471146
	Phase I/II PTK787/ZK 222584 and Gemcitabine in Advanced Pancreatic Cancer				Phase II, Phase I				PANC0002 95533, CPTK787AUS08, NCT00185588, PANC0002, NCT00185588
	Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer				Phase II, Phase I				05-233 NCT00307723
	Low Dose Radiation Therapy as Chemosensitizer in GI/ Ovarian Tumors				Phase II, Phase I				22706 NCT00390182
	A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma				Phase II, Phase I				0512000905 NCT00411762
	Chemoradiation With Oxaliplatin and 5FU for Locally Advanced Pancreatic Cancer				Phase II, Phase I				03-64 H11640, NCT00463840


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute